C20orf144
gene geneOn this page
Also known as dJ63M2.6bclt
Summary
C20orf144 (chromosome 20 open reading frame 144, HGNC:16137) is a protein-coding gene on chromosome 20q11.22, encoding Uncharacterized protein C20orf144 (Q9BQM9).
At a glance
- Clinical variants (ClinVar): 5 total
- MANE Select transcript:
NM_080825
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16137 |
| Approved symbol | C20orf144 |
| Name | chromosome 20 open reading frame 144 |
| Location | 20q11.22 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ63M2.6, bclt |
| Ensembl gene | ENSG00000149609 |
| Ensembl biotype | protein_coding |
| Entrez | 128864 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 retained_intron
ENST00000375222, ENST00000607738
RefSeq mRNA: 1 — MANE Select: NM_080825
NM_080825
CCDS: CCDS13223
Canonical transcript exons
ENST00000375222 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001466236 | 33663532 | 33663908 |
| ENSE00001466239 | 33662327 | 33662471 |
Expression profiles
Bgee: expression breadth ubiquitous, 124 present calls, max score 96.92.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0868 / max 91.5703, expressed in 3 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 184169 | 0.0662 | 3 |
| 184168 | 0.0152 | 3 |
| 184167 | 0.0053 | 3 |
Top tissues by expression
238 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 96.92 | gold quality |
| left testis | UBERON:0004533 | 96.85 | gold quality |
| testis | UBERON:0000473 | 92.46 | gold quality |
| adult organism | UBERON:0007023 | 83.46 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 73.19 | gold quality |
| sural nerve | UBERON:0015488 | 62.35 | gold quality |
| stromal cell of endometrium | CL:0002255 | 57.66 | gold quality |
| bone marrow cell | CL:0002092 | 57.04 | gold quality |
| parotid gland | UBERON:0001831 | 56.93 | gold quality |
| adrenal tissue | UBERON:0018303 | 56.35 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 55.27 | gold quality |
| pancreatic ductal cell | CL:0002079 | 55.11 | silver quality |
| right adrenal gland | UBERON:0001233 | 54.94 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 54.06 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| left ovary | UBERON:0002119 | 53.78 | gold quality |
| left adrenal gland | UBERON:0001234 | 53.70 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 53.41 | gold quality |
| adrenal gland | UBERON:0002369 | 53.34 | gold quality |
| adrenal cortex | UBERON:0001235 | 52.84 | gold quality |
| right ovary | UBERON:0002118 | 52.84 | gold quality |
| apex of heart | UBERON:0002098 | 52.83 | gold quality |
| colonic epithelium | UBERON:0000397 | 52.62 | gold quality |
| granulocyte | CL:0000094 | 52.45 | gold quality |
| adenohypophysis | UBERON:0002196 | 51.54 | gold quality |
| pituitary gland | UBERON:0000007 | 51.46 | gold quality |
| ovary | UBERON:0000992 | 50.94 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-83139 | no | 2.73 |
| E-ANND-3 | no | 1.28 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | 1700003F12Rik | ENSMUSG00000038523 |
| rattus_norvegicus | C3h20orf144 | ENSRNOG00000016583 |
Protein
Protein identifiers
Uncharacterized protein C20orf144 — Q9BQM9 (reviewed: Q9BQM9)
Alternative names: Bcl-2-like protein from testis
All UniProt accessions (1): Q9BQM9
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Preferentially expressed in the testis.
RefSeq proteins (1): NP_543015* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029296 | Bcl-2-like_put | Family |
Pfam: PF15318
UniProt features (8 total): region of interest 3, compositionally biased region 3, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BQM9-F1 | 59.13 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 6 (showing top):
chr20q11, MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED, BRUINS_UVC_RESPONSE_LATE, FOXN3_TARGET_GENES, GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_DN, GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
32 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C20orf144 | ACTL10 | Q5JWF8 | 607 |
| C20orf144 | NECAB3 | Q96P71 | 479 |
| C20orf144 | PXMP4 | Q9Y6I8 | 472 |
| C20orf144 | CBFA2T2 | O43439 | 398 |
| C20orf144 | BCL2L14 | Q9BZR8 | 365 |
| C20orf144 | PCYT1A | P49585 | 317 |
| C20orf144 | ST14 | Q9Y5Y6 | 290 |
| C20orf144 | TPCN1 | Q9ULQ1 | 248 |
| C20orf144 | MPL | P40238 | 228 |
| C20orf144 | F8 | P00451 | 223 |
| C20orf144 | GOLPH3 | Q9H4A6 | 178 |
| C20orf144 | PF4 | P02776 | 174 |
| C20orf144 | APAF1 | O14727 | 162 |
| C20orf144 | ABHD16B | Q9H3Z7 | 0 |
| C20orf144 | RLN3 | Q8WXF3 | 0 |
| C20orf144 | HSPB9 | Q9BQS6 | 0 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0U1RRK4, A0A1B0GVZ6, A0A1W2PPE3, A0A1W2PR82, A0A2R8Y2Y2, A0A2Z4LIS9, A0A494C0N9, A0A494C0Y3, A5A752, A5PKC7, A6NDZ8, A6NE82, A6NEL2, A6NJ08, A6NJI1, A6QP24, A6QPM6, A8MTW9, A8MXV6, A8MYA2, B1ARW8, O35182, O43541, O75474, O75638, O89113, O94850, P0C7X2, P24097, P50617, P70339, Q02080, Q2KID8, Q2KIS6, Q3UN58, Q5JPB2, Q63003, Q6NZ36, Q6UYE1, Q6ZSJ8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
5 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 3 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
339 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:33662459:G:GT | donor_gain | 1.0000 |
| 20:33662462:G:GT | donor_gain | 1.0000 |
| 20:33662477:G:GT | donor_gain | 1.0000 |
| 20:33662430:T:TA | donor_gain | 0.9900 |
| 20:33662459:G:T | donor_gain | 0.9900 |
| 20:33662468:GGCT:G | donor_gain | 0.9900 |
| 20:33662469:G:GT | donor_gain | 0.9900 |
| 20:33662469:GCT:G | donor_gain | 0.9900 |
| 20:33662472:G:GG | donor_gain | 0.9900 |
| 20:33663530:A:AG | acceptor_gain | 0.9900 |
| 20:33663531:G:GG | acceptor_gain | 0.9900 |
| 20:33663531:GACCA:G | acceptor_gain | 0.9900 |
| 20:33662401:A:T | donor_gain | 0.9800 |
| 20:33662431:G:GA | donor_gain | 0.9800 |
| 20:33662460:A:T | donor_gain | 0.9800 |
| 20:33662478:G:T | donor_gain | 0.9800 |
| 20:33662489:G:T | donor_gain | 0.9800 |
| 20:33663527:CCCA:C | acceptor_loss | 0.9800 |
| 20:33663528:CCA:C | acceptor_loss | 0.9800 |
| 20:33663530:AGACC:A | acceptor_loss | 0.9800 |
| 20:33663531:GA:G | acceptor_gain | 0.9800 |
| 20:33662432:G:GT | donor_gain | 0.9700 |
| 20:33662470:C:G | donor_gain | 0.9500 |
| 20:33662470:CTGT:C | donor_loss | 0.9500 |
| 20:33662471:TGTG:T | donor_loss | 0.9500 |
| 20:33662473:T:G | donor_loss | 0.9500 |
| 20:33662489:G:GT | donor_gain | 0.9500 |
| 20:33663531:GACC:G | acceptor_gain | 0.9500 |
| 20:33662467:CGGCT:C | donor_gain | 0.9400 |
| 20:33662468:GGCTG:G | donor_gain | 0.9400 |
AlphaMissense
962 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:33663548:T:C | I48T | 0.856 |
| 20:33663548:T:G | I48S | 0.772 |
| 20:33663539:T:G | I45S | 0.764 |
| 20:33662354:C:A | N3K | 0.759 |
| 20:33662354:C:G | N3K | 0.759 |
| 20:33663539:T:A | I45N | 0.718 |
| 20:33663542:T:A | V46E | 0.704 |
| 20:33663548:T:A | I48N | 0.703 |
| 20:33663683:T:C | M93T | 0.684 |
| 20:33663545:T:C | L47P | 0.680 |
| 20:33662349:G:A | G2R | 0.628 |
| 20:33662349:G:C | G2R | 0.628 |
| 20:33662350:G:T | G2V | 0.628 |
| 20:33662439:T:C | F32L | 0.619 |
| 20:33662441:C:A | F32L | 0.619 |
| 20:33662441:C:G | F32L | 0.619 |
| 20:33662353:A:T | N3I | 0.616 |
| 20:33662432:G:C | W29C | 0.613 |
| 20:33662432:G:T | W29C | 0.613 |
| 20:33663539:T:C | I45T | 0.608 |
| 20:33663684:G:A | M93I | 0.603 |
| 20:33663684:G:C | M93I | 0.603 |
| 20:33663684:G:T | M93I | 0.603 |
| 20:33662378:A:C | K11N | 0.599 |
| 20:33662378:A:T | K11N | 0.599 |
| 20:33663644:T:C | L80S | 0.586 |
| 20:33663545:T:A | L47Q | 0.580 |
| 20:33662374:C:T | T10I | 0.572 |
| 20:33662350:G:A | G2E | 0.567 |
dbSNP variants (sampled 300 via entrez): RS1000197218 (20:33660914 C>G), RS1001928592 (20:33662021 G>C), RS1002171229 (20:33663460 C>A,G,T), RS1002203850 (20:33663287 C>T), RS1002539055 (20:33664261 G>A,C), RS1003175426 (20:33664392 C>G), RS1003528727 (20:33660501 C>G,T), RS1004004507 (20:33663278 G>A,C), RS1004271119 (20:33663892 TAA>T), RS1005383456 (20:33663208 G>A), RS1005845676 (20:33662983 C>G), RS1006798387 (20:33661862 G>A), RS1007110745 (20:33663902 G>A,C), RS1007418819 (20:33661268 G>A), RS1007469239 (20:33664174 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| jinfukang | affects cotreatment, increases expression | 1 |
| MT19c compound | decreases expression | 1 |
| Cadmium | increases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.